💨 Abstract
The US Food and Drug Administration (FDA) has approved the nasal influenza vaccine FluMist by AstraZeneca for self-administration, making it the first such vaccine in the US. It is administered via a spray in the nose and can be taken by individuals aged 2 to 49. The vaccine contains a weakened form of live influenza virus strains and is sprayed in the nose, and a prescription is still required to receive it.
Courtesy: theprint.in
Summarized by Einstein Beta 🤖
Suggested
Delhi Ranji Probables: Kohli, Pant named in 84, no Ishant
Over 36% voting till 1 PM in J-K
Probe into death of Badlapur sexual assault case accused should be fair, impartial: HC
Stocks slip as China buoyed by stimulus rally
We did not do justice to our talent, potential: Bangladesh coach Hathurusinghe
Hezbollah's tunnels and flexible command weather Israel's deadly blows
‘Take my words back,’ says Kangana after BJP miffed over her ‘farmers laws’ comments
Apollo Spectra Unveils Robotic Knee Replacement Procedure In Mumbai
Polestar Solutions, the Leading AI & Analytics Company, Becomes Great Place to Work® Certified™ in India
China's military presence intensifies around Taiwan, triggers alert
Powered by MessengerX.io